CYH Earnings

CYH reported its earnings on 2026-02-18, showcasing a revenue of 3.11B against an estimate of 3.14B, resulting in a -1.08% surprise. The EPS was 0, surpassing the expected -0.32 by 100%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CYH's earnings announcement on 2026-02-18, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CYH's stock price tends to shift by an average of -5.04% in the 10 days leading up to earnings and -2.4% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CYH's annual revenue to reach 3.18B, while the EPS is projected at -0.20. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CYH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CYH's stock price typically moves by -5.04% in the 10 days before its earnings and -2.4% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.20 and revenue of 3.18B.

The earnings call reveals mixed signals. Financial performance shows slight improvements in margins and leverage, but operational challenges persist with declining surgeries and ER visits. The cautious guidance and lack of specific divestiture plans contribute to uncertainty. However, positive factors like payer mix improvements and strategic capital deployment balance the sentiment. Overall, the sentiment remains neutral due to the absence of decisive positive or negative catalysts.